Bartlett & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $489K | Hold |
6,375
| – | – | 0.01% | 354 |
|
|
2023
Q3 | $442K | Hold |
6,375
| – | – | 0.01% | 351 |
|
|
2023
Q2 | $601K | Hold |
6,375
| – | – | 0.01% | 320 |
|
|
2023
Q1 | $527K | Hold |
6,375
| – | – | 0.01% | 284 |
|
|
2022
Q4 | $476K | Hold |
6,375
| – | – | 0.01% | 301 |
|
|
2022
Q3 | $527K | Hold |
6,375
| – | – | 0.01% | 277 |
|
|
2022
Q2 | $606K | Sell |
6,375
-408
| -6% | -$42.2K | 0.01% | 260 |
|
|
2022
Q1 | $798K | Hold |
6,783
| – | – | 0.01% | 245 |
|
|
2021
Q4 | $879K | Buy |
6,783
+240
| +4% | +$28K | 0.01% | 243 |
|
|
2021
Q3 | $741K | Sell |
6,543
-6
| -0.1% | -$685 | 0.01% | 229 |
|
|
2021
Q2 | $678K | Hold |
6,549
| – | – | 0.01% | 231 |
|
|
2021
Q1 | $548K | Hold |
6,549
| – | – | 0.01% | 252 |
|
|
2020
Q4 | $597K | Sell |
6,549
-84
| -1% | -$6.97K | 0.01% | 235 |
|
|
2020
Q3 | $529K | Hold |
6,633
| – | – | 0.01% | 236 |
|
|
2020
Q2 | $458K | Sell |
6,633
-1,140
| -15% | -$81K | 0.01% | 243 |
|
|
2020
Q1 | $489K | Buy |
+7,773
| New | +$561K | 0.01% | 230 |
|
|
2019
Q3 | $639K | Buy |
8,718
+2,310
| +36% | +$162K | 0.02% | 235 |
|
|
2019
Q2 | $395K | Hold |
6,408
| – | – | 0.01% | 214 |
|
|
2019
Q1 | $409K | Hold |
6,408
| – | – | 0.02% | 212 |
|
|
2018
Q4 | $327K | Hold |
6,408
| – | – | 0.01% | 222 |
|
|
2018
Q3 | $372K | Hold |
6,408
| – | – | 0.01% | 217 |
|
|
2018
Q2 | $311K | Sell |
6,408
-408
| -6% | -$19K | 0.01% | 222 |
|
|
2018
Q1 | $317K | Sell |
6,816
-408
| -6% | -$17.7K | 0.01% | 220 |
|
|
2017
Q4 | $271K | Hold |
7,224
| – | – | 0.01% | 230 |
|
|
2017
Q3 | $263K | Hold |
7,224
| – | – | 0.01% | 230 |
|
|
2017
Q2 | $285K | Hold |
7,224
| – | – | 0.01% | 222 |
|
|
2017
Q1 | $227K | Hold |
7,224
| – | – | 0.01% | 243 |
|
|
2016
Q4 | $226K | Hold |
7,224
| – | – | 0.01% | 236 |
|
|
2016
Q3 | $290K | Hold |
7,224
| – | – | 0.01% | 222 |
|
|
2016
Q2 | $240K | Hold |
7,224
| – | – | 0.01% | 234 |
|
|
2016
Q1 | $212K | Hold |
7,224
| – | – | 0.01% | 242 |
|
|
2015
Q4 | $190K | Hold |
7,224
| – | – | 0.01% | 255 |
|
|
2015
Q3 | $171K | Hold |
7,224
| – | – | 0.01% | 259 |
|
|
2015
Q2 | $171K | Hold |
7,224
| – | – | 0.01% | 273 |
|
|
2015
Q1 | $172K | Hold |
7,224
| – | – | 0.01% | 271 |
|
|
2014
Q4 | $153K | Hold |
7,224
| – | – | 0.01% | 281 |
|
|
2014
Q3 | $123K | Hold |
7,224
| – | – | 0.01% | 293 |
|
|
2014
Q2 | $103K | Hold |
7,224
| – | – | 0.01% | 308 |
|
|
2014
Q1 | $89K | Hold |
7,224
| – | – | ﹤0.01% | 329 |
|
|
2013
Q4 | $79K | Hold |
7,224
| – | – | ﹤0.01% | 346 |
|
|
2013
Q3 | $84K | Hold |
7,224
| – | – | ﹤0.01% | 324 |
|
|
2013
Q2 | $81K | Buy |
+7,224
| New | +$85.5K | ﹤0.01% | 320 |
|
Other funds holding EW
Bartlett & Co's EW Position: Q4 2023 in Review
Bartlett & Co held its Edwards Lifesciences (EW) position steady in Q4 2023 at 6,375 shares worth $489K. The position accounts for 0.01% of the portfolio, ranked #354.
Bartlett & Co first reported a position in EW in Q2 2013 and has held it in 42 quarters since. The position peaked at $879K in Q4 2021. 1,244 funds tracked by Wall St. Rank hold EW as of Q4 2023.
- Bartlett & Co held 6,375 shares of Edwards Lifesciences worth $489K as of Q4 2023.
- Bartlett & Co left its Edwards Lifesciences share count unchanged in Q4 2023.
- Edwards Lifesciences made up 0.01% of Bartlett & Co's portfolio in Q4 2023, its #354 holding.
- Bartlett & Co first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 42 quarters since.
- Bartlett & Co's Edwards Lifesciences position peaked at $879K in Q4 2021.
- 1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.